EDGAR Filing Documents for 0001541157-15-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001541157-15-000002

Filing Date

2015-09-28

Accepted

2015-09-28 13:54:44

Documents

Effectiveness Date

2015-09-28

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	14251
	Complete submission text file	0001541157-15-000002.txt		15567

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-248315 | Film No.: 151126952
SIC: 2834 Pharmaceutical Preparations